Carole Nuechterlein's Net Worth
$0
Who is Carole Nuechterlein?
Carole Nuechterlein does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Entrada Therapeutics, Inc., BCTG Acquisition Corp., Aligos Therapeutics, Inc., Millendo Therapeutics, Inc., and AveXis, Inc..
SEC CIK
Carole Nuechterlein's CIK is 0001665133
Past Insider Trading and Trends
2016 was Carole Nuechterlein's most active year for acquiring shares with 2 total transactions. Carole Nuechterlein's most active month to acquire stocks was the month of May. 2024 was Carole Nuechterlein's most active year for disposing of shares, totalling 1 transactions. Carole Nuechterlein's most active month to dispose stocks was the month of January. 2024 saw Carole Nuechterlein paying a total of $0.00 for 64,411 shares, this is the most they've acquired in one year. In 2024 Carole Nuechterlein cashed out on 15,000 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Entrada Therapeutics, Inc. (TRDA) Snapshot price: $14.8
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
BCTG Acquisition Corp. (TNGX) Snapshot price: $10.89
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Aligos Therapeutics, Inc. (ALGS) Snapshot price: $14
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27 - Feb 28
| |||
Form 4
| +256.56% | 7.93M |
$0.76 | $6,004,149.24 | 11.03M |
Oct 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
∞
| 3.09M |
—
|
—
| 3.09M |
Oct 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Millendo Therapeutics, Inc. (TPST) Snapshot price: $1.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
AveXis, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |